GT BIOPHARMA, INC. (GTBP) Operating cash flow 2016–2025
GT BIOPHARMA, INC. (GTBP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.9MFY2025 · since FY2016: -$1.9M → -$12.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.9M | -0.1% |
| FY2024 | -$12.9M | -45.8% |
| FY2023 | -$8.9M | +41.8% |
| FY2022 | -$15.2M | +2.5% |
| FY2021 | -$15.6M | -114.9% |
| FY2020 | -$7.3M | -98.5% |
| FY2019 | -$3.7M | +65.7% |
| FY2018 | -$10.7M | -96.6% |
| FY2017 | -$5.4M | -181.3% |
| FY2016 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice